(Q43572717)

24 November 2017

Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma (English)

1 reference

24 November 2017

1

Peggy L Porter

1 reference

24 November 2017

6

Elaine W Flagg

1 reference

24 November 2017

7

Ralph J Coates

1 reference

24 November 2017

Mary Jo Lund

2

1 reference

24 November 2017

Ming Gang Lin

3

1 reference

24 November 2017

Xiaopu Yuan

4

1 reference

24 November 2017

Jonathan M Liff

5

1 reference

24 November 2017

J William Eley

8

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

24 November 2017

1 reference

24 November 2017

100

1 reference

24 November 2017

2533-2542

1 reference

24 November 2017

12

1 reference

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

24 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

Race, socioeconomic status, and breast cancer treatment and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

Breast cancer in black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

Differences in breast cancer stage, treatment, and survival by race and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Breast cancer stage at diagnosis: Caucasians versus Afro-Americans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Ethnic differences in risk and prognostic factors for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Cyclin E and survival in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

G1-S transition defects occur in most breast cancers and predict outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Oral contraceptives and breast cancer risk among younger women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Immunohistological study of oestrogen receptors in breast carcinomas that are biochemically receptor negative

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

A novel cyclin encoded by a bcl1-linked candidate oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Breast carcinoma tumor characteristics in black and white women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Breast cancer in African American women: epidemiology and tumor biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Histopathology of breast cancer among African-American women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Cyclins and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Multiparameter analyses of cell cycle regulatory proteins in human breast cancer: a key to definition of separate pathways in tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Cyclin D1 and prognosis in human breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.20279

1 reference

7 January 2021

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Disaggregating the effects of race and poverty on breast cancer outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Dual effect of parity on breast cancer risk in African-American women.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20279

7 January 2021

Identifiers

DOI

10.1002/CNCR.20279

1 reference

24 November 2017

1 reference